The DOI matches its Crossref record; 247 of the 247 references it cites were found in a registry or an index.
BCL-2 protein family: attractive targets for cancer therapy
Open accessAbstract
Acquired resistance to cell death is a hallmark of cancer. The BCL-2 protein family members play important roles in controlling apoptotic cell death. Abnormal over-expression of pro-survival BCL-2 family members or abnormal reduction of pro-apoptotic BCL-2 family proteins, both resulting in the inhibition of apoptosis, are frequently detected in diverse malignancies. The critical role of the pro-survival and pro-apoptotic BCL-2 family proteins in the regulation of apoptosis makes them attractive targets for the development of agents for the treatment of cancer. This review describes the roles of the various pro-survival and pro-apoptotic members of the BCL-2 protein family in normal development and organismal function and how defects in the control of apoptosis promote the development and therapy resistance of cancer. Finally, we discuss the development of inhibitors of pro-survival BCL-2 proteins, termed BH3-mimetic drugs, as novel agents for cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: New Dimensions
Hanahan, D. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1059 · Cited by 9,887
Apoptosis in the Pathogenesis and Treatment of Disease
Thompson, C. B. (1995) · Science · doi:10.1126/science.7878464 · Cited by 6,524
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc839 · Cited by 6,056
The Bcl-2 Protein Family: Arbiters of Cell Survival
Adams, J. M., & Cory, S. (1998) · Science · doi:10.1126/science.281.5381.1322 · Cited by 5,332
The BCL-2 protein family: opposing activities that mediate cell death
Youle, R. J., & Strasser, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2308 · Cited by 4,679
Self-citationThe landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
Czabotar, P. E., Lessene, G., Strasser, A., & Adams, J. M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3722 · Cited by 3,219
Self-citationbcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
Boise, L. H., González-García, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nuñez, G., & Thompson, C. B. (1993) · Cell · doi:10.1016/0092-8674(93)90508-n · Cited by 3,087
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Souers, A. J., Leverson, J. D., Boghaert, E. R., Ackler, S. L., Catron, N. D., Chen, J., Dayton, B. D., Ding, H., Enschede, S. H., Fairbrother, W. J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3048 · Cited by 3,058
Regulation and Function of NF-κB Transcription Factors in the Immune System
Vallabhapurapu, S., & Karin, M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132641 · Cited by 2,588
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81780-8 · Cited by 2,551
PUMA, a Novel Proapoptotic Gene, Is Induced by p53
Nakano, K., & Vousden, K. H. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00214-3 · Cited by 2,315
Drug delivery with carbon nanotubes for in vivo cancer treatment
Liu, Z., Chen, K., Davis, C. R., Sherlock, S. P., Cao, Q., Chen, X. S., & Dai, H. (2008) · PubMed · doi:10.48550/arxiv.0808.2070 · Cited by 2,286
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., & Tanaka, †. N. (2000) · Science · doi:10.1126/science.288.5468.1053 · Cited by 2,112
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
Tse, C., Shoemaker, A. R., Adickes, J., Anderson, M. G., Chen, J., Jin, S., Johnson, E. F., Marsh, K. C., Mitten, M. J., Nimmer, P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5836 · Cited by 1,992
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
Roberts, A. W., Davids, M. S., Pagel, J. M., Kahl, B. S., Puvvada, S. D., Gerecitano, J. F., Kipps, T. J., Anderson, M. A., Brown, J. R., Gressick, L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1513257 · Cited by 1,900
Chen, L., Willis, S. N., Wei, A., Smith, B. J., Fletcher, J. I., Hinds, M. G., Colman, P. M., Day, C. L., Adams, J. M., & Huang, D. C. S. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.030 · Cited by 1,816
Movement of Bax from the Cytosol to Mitochondria during Apoptosis
Wolter, K. G., Hsu, Y.-T., Smith, C. L., Nechushtan, A., Xi, X.-G., & Youle, R. J. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.5.1281 · Cited by 1,806
Involvement of the bcl -2 Gene in Human Follicular Lymphoma
Tsujimoto, Y., Cossman, J., Jaffe, E., & Croce, C. M. (1985) · Science · doi:10.1126/science.3874430 · Cited by 1,786
Veis, D. J., Sorenson, C. M., Shutter, J. R., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)80065-m · Cited by 1,628
Bouillet, P., Metcalf, D., Huang, D. C. S., Tarlinton, D. M., Kay, T. W. H., Köntgen, F., Adams, J. M., & Strasser, A. (1999) · Science · doi:10.1126/science.286.5445.1735 · Cited by 1,504
Self-citationLindsten, T., Ross, A. J., King, A., Zong, W.-X., Rathmell, J. C., Shiels, H. A., Ulrich, E., Waymire, K. G., Mahar, P., Frauwirth, K., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00136-2 · Cited by 1,489
Strasser, A., O'Connor, L., & Dixit, V. M. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.217 · Cited by 1,351
Self-citationp53- and Drug-Induced Apoptotic Responses Mediated by BH3-Only Proteins Puma and Noxa
Villunger, A., Michalak, E. M., Coultas, L., Müllauer, F., Böck, G., Ausserlechner, M. J., Adams, J. M., & Strasser, A. (2003) · Science · doi:10.1126/science.1090072 · Cited by 1,327
Self-citationPUMA Induces the Rapid Apoptosis of Colorectal Cancer Cells
Yu, J., Zhang, L., Hwang, P. M., Kinzler, K. W., & Vogelstein, B. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00213-1 · Cited by 1,280
Willis, S. N., Chen, L., Dewson, G., Wei, A., Naik, E., Fletcher, J. I., Adams, J. M., & Huang, D. C. S. (2005) · Genes & Development · doi:10.1101/gad.1304105 · Cited by 1,233
Kuwana, T., Bouchier-Hayes, L., Chipuk, J. E., Bonzon, C., Sullivan, B. A., Green, D. R., & Newmeyer, D. D. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.003 · Cited by 1,185
Massive Cell Death of Immature Hematopoietic Cells and Neurons in Bcl-x-Deficient Mice
Motoyama, N., Wang, F., Roth, K. A., Sawa, H., Nakayama, K.-I., Nakayama, K., Negishi, I., Senju, S., Zhang, Q., Fujii, S., et al. (1995) · Science · doi:10.1126/science.7878471 · Cited by 1,163
JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis
Lei, K., & Davis, R. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438011100 · Cited by 1,068
Konopleva, M., Pollyea, D. A., Potluri, J., Chyla, B., Hogdal, L., Busman, T., McKeegan, E., Salem, A. H., Zhu, M., Ricker, J. L., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0313 · Cited by 1,064
Cell death induced by endoplasmic reticulum stress
Iurlaro, R., & Muñoz‐Pinedo, C. (2016) · The FEBS Journal · doi:10.1111/febs.13598 · Cited by 1,062
Puthalakath, H., Huang, D. C. S., O’Reilly, L. A., King, S. M., & Strasser, A. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80456-6 · Cited by 1,054
Self-citationbcl-2 transgene inhibits T cell death and perturbs thymic self-censorship
Strasser, A., Harris, A. W., & Cory, S. (1991) · Cell · doi:10.1016/0092-8674(91)90362-3 · Cited by 1,054
Self-citationThe MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
Kotschy, A., Szlavik, Z., Murray, J., Davidson, J., Maragno, A. L., Le Toumelin-Braizat, G., Chanrion, M., Kelly, G. L., Gong, J.-N., Moujalled, D. M., et al. (2016) · Nature · doi:10.1038/nature19830 · Cited by 1,047
Self-citationBH3-Only Proteins—Essential Initiators of Apoptotic Cell Death
Huang, D. C. S., & Strasser, A. (2000) · Cell · doi:10.1016/s0092-8674(00)00187-2 · Cited by 1,043
Self-citationProgrammed Anuclear Cell Death Delimits Platelet Life Span
Mason, K. D., Carpinelli, M. R., Fletcher, J. I., Collinge, J. E., Hilton, A. A., Ellis, S., Kelly, P. N., Ekert, P. G., Metcalf, D., Roberts, A. W., et al. (2007) · Cell · doi:10.1016/j.cell.2007.01.037 · Cited by 1,031
Dijkers, P. F., Medema†, R. H., Lammers, J.-W. J., Koenderman, L., & Coffer, P. J. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00728-4 · Cited by 976
MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2.
Kozopas, K. M., Yang, T., Buchan, H. L., Zhou, P., & Craig, R. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3516 · Cited by 961
Control of mitochondrial apoptosis by the Bcl-2 family
Brunelle, J. K., & Letai, A. (2009) · Journal of Cell Science · doi:10.1242/jcs.031682 · Cited by 929
Cleary, M. L., & Sklar, J. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.21.7439 · Cited by 924
Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2
Strasser, A., Harris, A. W., Bath, M. L., & Cory, S. (1990) · Nature · doi:10.1038/348331a0 · Cited by 905
Self-citationMaurer, U., Charvet, C., Wagman, A. S., Dejardin, E., & Green, D. R. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.02.009 · Cited by 881
Bcl-2 family proteins and cancer
Yip, K. W., & Reed, J. C. (2008) · Oncogene · doi:10.1038/onc.2008.307 · Cited by 881
Puma is an essential mediator of p53-dependent and -independent apoptotic pathways
Jeffers, J. R., Parganas, E., Lee, Y., Yang, C., Wang, J., Brennan, J., MacLean, K. H., Han, J., Chittenden, T., Ihle, J. N., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00244-7 · Cited by 879
Wilson, W. H., O'Connor, O. A., Czuczman, M. S., LaCasce, A. S., Gerecitano, J. F., Leonard, J. P., Tulpule, A., Dunleavy, K., Xiong, H., Chiu, Y.-L., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70261-8 · Cited by 876
Zhong, Q., Gao, W., Du, F., & Wang, X. (2005) · Cell · doi:10.1016/j.cell.2005.06.009 · Cited by 842
Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1
Opferman, J. T., Letai, A., Beard, C., Sorcinelli, M. D., Ong, C. C., & Korsmeyer, S. J. (2003) · Nature · doi:10.1038/nature02067 · Cited by 801
Bcl‐2 and Fas/APO‐1 regulate distinct pathways to lymphocyte apoptosis.
Strasser, A., Harris, A. W., Huang, D. C., Krammer, P. H., & Cory, S. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00304.x · Cited by 784
Self-citationMitochondrial apoptosis: killing cancer using the enemy within
Lopez, J., & Tait, S. W. G. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.85 · Cited by 784
Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies
Delbridge, A. R. D., Grabow, S., Strasser, A., & Vaux, D. L. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2015.17 · Cited by 752
Self-citationPuthalakath, H., & Strasser, A. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400998 · Cited by 722
Self-citationbcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia
Hanada, M., Delia, D., Aiello, A., Stadtmauer, E., & Reed, J. (1993) · Blood · doi:10.1182/blood.v82.6.1820.1820 · Cited by 673
Strasser, A. (1994) · Cell · doi:10.1016/0092-8674(94)90201-1 · Cited by 666
Self-citationTsujimoto, Y., Yunis, J., Onorato-Showe, L., Erikson, J., Nowell, P. C., & Croce, C. M. (1984) · Science · doi:10.1126/science.6610211 · Cited by 652
Kitada, S., Andersen, J., Akar, S., Zapata, J. M., Takayama, S., Krajewski, S., Wang, H.-G., Zhang, X., Bullrich, F., Croce, C. M., et al. (1998) · Blood · doi:10.1182/blood.v91.9.3379 · Cited by 651
SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction
Inuzuka, H., Shaik, S., Onoyama, I., Gao, D., Tseng, A., Maser, R. S., Zhai, B., Wan, L., Gutierrez, A., Lau, A. W., et al. (2011) · Nature · doi:10.1038/nature09732 · Cited by 632
Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival
Schwickart, M., Huang, X., Lill, J. R., Liu, J., Ferrando, R., French, D. M., Maecker, H., O’Rourke, K., Bazan, F., Eastham-Anderson, J., et al. (2010) · Nature · doi:10.1038/nature08646 · Cited by 628
Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.
Krajewska, M., Krajewski, S., Epstein, J. I., Shabaik, A. S., Sauvageot, J., Song, K. B., Kitada, S., & Reed, J. C. (1996) · Europe PMC (PubMed Central) · Cited by 593
Wang, C.-Y., Guttridge, D. C., Mayo, M. W., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.5923 · Cited by 590
Obligate Role of Anti-Apoptotic MCL-1 in the Survival of Hematopoietic Stem Cells
Opferman, J. T., Iwasaki, H., Ong, C. C., Suh, H., Mizuno, S.-I., Akashi, K., & Korsmeyer, S. J. (2005) · Science · doi:10.1126/science.1106114 · Cited by 574
The p53/p63/p73 family of transcription factors: overlapping and distinct functions
Levrero, M., Laurenzi, V. D., Costanzo, A., Sabatini, S., Gong, J., Wang, J. Y. J., & Melino, G. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.10.1661 · Cited by 565
Leverson, J. D., Phillips, D. C., Mitten, M. J., Boghaert, E. R., Diaz, D., Tahir, S. K., Belmont, L. D., Nimmer, P., Xiao, Y., Ma, X. M., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa4642 · Cited by 541
Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer
Catz, S. D., & Johnson, J. L. (2001) · Oncogene · doi:10.1038/sj.onc.1204926 · Cited by 538
Mcl‐1; the molecular regulation of protein function
Thomas, L. W., Lam, C., & Edwards, S. W. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.05.061 · Cited by 538
Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases
Strasser, A., Cory, S., & Adams, J. M. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.307 · Cited by 532
Self-citationLee, H. H., Dadgostar, H., Cheng, Q., Shu, J., & Cheng, G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9136 · Cited by 521
JNK-Mediated BIM Phosphorylation Potentiates BAX-Dependent Apoptosis
Putcha, G. V., Le, S., Frank, S., Besirli, C. G., Clark, K., Chu, B., Alix, S., Youle, R. J., LaMarche, A., Maroney, A. C., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00355-6 · Cited by 518
Phosphorylation of Bcl2 and regulation of apoptosis
Ruvolo, P., Deng, X., & May, W. (2001) · Leukemia · doi:10.1038/sj.leu.2402090 · Cited by 504
Tron, A. E., Belmonte, M. A., Adam, A., Aquila, B. M., Boise, L. H., Chiarparin, E., Cidado, J., Embrey, K. J., Gangl, E., Gibbons, F. D., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07551-w · Cited by 490
Bim is a suppressor of Myc-induced mouse B cell leukemia
Egle, A., Harris, A. W., Bouillet, P., & Cory, S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401471101 · Cited by 488
TRAIL signalling: Decisions between life and death
Falschlehner, C., Emmerich, C. H., Gerlach, B., & Walczak, H. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.02.007 · Cited by 458
Distinct Thresholds Govern Myc's Biological Output In Vivo
Murphy, D. J., Junttila, M. R., Pouyet, L., Karnezis, A., Shchors, K., Bui, D. A., Brown-Swigart, L., Johnson, L., & Evan, G. I. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.018 · Cited by 456
Genetic dissection of the miR-17∼92 cluster of microRNAs in Myc-induced B-cell lymphomas
Mu, P., Han, Y.-C., Betel, D., Yao, E., Squatrito, M., Ogrodowski, P., de Stanchina, E., D'Andrea, A., Sander, C., & Ventura, A. (2009) · Genes & Development · doi:10.1101/gad.1872909 · Cited by 452
Leverson, J. D., Zhang, H., Chen, J., Tahir, S. K., Phillips, D. C., Xue, J., Nimmer, P., Jin, S., Smith, M., Xiao, Y., et al. (2015) · Cell Death & Disease · doi:10.1038/cddis.2014.561 · Cited by 440
Caenepeel, S., Brown, S. P., Belmontes, B., Moody, G., Keegan, K. S., Chui, D., Whittington, D. A., Huang, X., Poppe, L., Cheng, A. C., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0387 · Cited by 432
Merry, D. E., Veis, D. J., Hickey, W. F., & Korsmeyer, S. J. (1994) · Development · doi:10.1242/dev.120.2.301 · Cited by 426
Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia
Glaser, S. P., Lee, E. F., Trounson, E., Bouillet, P., Wei, A., Fairlie, W. D., Izon, D. J., Zuber, J., Rappaport, A. R., Herold, M. J., et al. (2012) · Genes & Development · doi:10.1101/gad.182980.111 · Cited by 423
Self-citationExpression of bcl-xL can confer a multidrug resistance phenotype
Minn, A., Rudin, C., Boise, L., & Thompson, C. (1995) · Blood · doi:10.1182/blood.v86.5.1903.bloodjournal8651903 · Cited by 415
FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal
You, H., Pellegrini, M., Tsuchihara, K., Yamamoto, K., Hacker, G., Erlacher, M., Villunger, A., & Mak, T. W. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060353 · Cited by 412
Slug Antagonizes p53-Mediated Apoptosis of Hematopoietic Progenitors by Repressing puma
Wu, W.-S., Heinrichs, S., Xu, D., Garrison, S. P., Zambetti, G. P., Adams, J. M., & Look, A. T. (2005) · Cell · doi:10.1016/j.cell.2005.09.029 · Cited by 398
Mcl-1 deficiency results in peri-implantation embryonic lethality
Rinkenberger, J. L., Horning, S., Klocke, B., Roth, K., & Korsmeyer, S. J. (2000) · Genes & Development · doi:10.1101/gad.14.1.23 · Cited by 397
Nakayama, K., Nakayama, K., Negishi, I., Kuida, K., Sawa, H., & Loh, D. Y. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3700 · Cited by 395
Ding, Q., He, X., Hsu, J.-M., Xia, W., Chen, C.-T., Li, L.-Y., Lee, D.-F., Liu, J.-C., Zhong, Q., Wang, X., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00620-06 · Cited by 393
Petrocca, F., Vecchione, A., & Croce, C. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1768 · Cited by 385
Structure-guided design of a selective BCL-XL inhibitor
Lessene, G., Czabotar, P. E., Sleebs, B. E., Zobel, K., Lowes, K. N., Adams, J. M., Baell, J. B., Colman, P. M., Deshayes, K., Fairbrother, W. J., et al. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1246 · Cited by 381
The role of c-myc in cellular growth control
Schmidt, E. V. (1999) · Oncogene · doi:10.1038/sj.onc.1202751 · Cited by 380
Horita, M., Andreu, E. J., Benito, A., Arbona, C., Sanz, C., Benet, I., Prosper, F., & Fernandez-Luna, J. L. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.6.977 · Cited by 366
Harley, M. E., Allan, L. A., Sanderson, H. S., & Clarke, P. R. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.112 · Cited by 353
Anti-apoptotic BCL-2 family members in development
Opferman, J. T., & Kothari, A. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.170 · Cited by 347
The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs
Diepstraten, S. T., Anderson, M. A., Czabotar, P. E., Lessene, G., Strasser, A., & Kelly, G. L. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-021-00407-4 · Cited by 346
Self-citationBcl-2–family proteins and hematologic malignancies: history and future prospects
Reed, J. C. (2008) · Blood · doi:10.1182/blood-2007-09-078162 · Cited by 345
Cragg, M. S., Kuroda, J., Puthalakath, H., Huang, D. C. S., & Strasser, A. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040316 · Cited by 343
Self-citationKuroda, J., Puthalakath, H., Cragg, M. S., Kelly, P. N., Bouillet, P., Huang, D. C. S., Kimura, S., Ottmann, O. G., Druker, B. J., Villunger, A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606176103 · Cited by 336
Self-citationApoptosis regulator Bcl-w is essential for spermatogenesis but appears otherwise redundant
Print, C. G., Loveland, K. L., Gibson, L., Meehan, T., Stylianou, A., Wreford, N., de Kretser, D., Metcalf, D., Köntgen, F., Adams, J. M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12424 · Cited by 335
Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study
Seymour, J. F., Ma, S., Brander, D. M., Choi, M. Y., Barrientos, J., Davids, M. S., Anderson, M. A., Beaven, A. W., Rosen, S. T., Tam, C. S., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30012-8 · Cited by 333
Mcl-1 is a potential therapeutic target in multiple types of cancer
Akgul, C. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8637-6 · Cited by 329
p63 and p73, the ancestors of p53
Dotsch, V., Bernassola, F., Coutandin, D., Candi, E., & Melino, G. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004887 · Cited by 326
O'Neill, K. L., Huang, K., Zhang, J., Chen, Y., & Luo, X. (2016) · Genes & Development · doi:10.1101/gad.276725.115 · Cited by 323
Mcl-1 is essential for the survival of plasma cells
Peperzak, V., Vikström, I., Walker, J., Glaser, S. P., LePage, M., Coquery, C. M., Erickson, L. D., Fairfax, K., Mackay, F., Strasser, A., et al. (2013) · Nature Immunology · doi:10.1038/ni.2527 · Cited by 320
Self-citationDiscovery of a Potent and Selective BCL-X L Inhibitor with in Vivo Activity
Tao, Z.-F., Hasvold, L., Wang, L., Wang, X., Petros, A. M., Park, C. H., Boghaert, E. R., Catron, N. D., Chen, J., Colman, P. M., et al. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml5001867 · Cited by 309
Harris, C. A., & Johnson, E. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104073200 · Cited by 307
Tagawa, H., Karnan, S., Suzuki, R., Matsuo, K., Zhang, X., Ota, A., Morishima, Y., Nakamura, S., & Seto, M. (2005) · Oncogene · doi:10.1038/sj.onc.1208300 · Cited by 307
Targeting MCL-1 in cancer: current status and perspectives
Wang, H., Guo, M., Wei, H., & Chen, Y. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01079-1 · Cited by 301
Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis
Rathmell, J. C., Lindsten, T., Zong, W.-X., Cinalli, R. M., & Thompson, C. B. (2002) · Nature Immunology · doi:10.1038/ni834 · Cited by 297
Bhattacharya, S., Ray, R. M., & Johnson, L. R. (2005) · Biochemical Journal · doi:10.1042/bj20050465 · Cited by 291
Valente, L. J., Gray, D. H. D., Michalak, E. M., Pinon-Hofbauer, J., Egle, A., Scott, C. L., Janic, A., & Strasser, A. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.04.012 · Cited by 291
Self-citationTreatment of Relapsed Acute Myeloid Leukemia
Thol, F., & Ganser, A. (2020) · Current Treatment Options in Oncology · doi:10.1007/s11864-020-00765-5 · Cited by 288
BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines
Merino, D., Kelly, G. L., Lessene, G., Wei, A. H., Roberts, A. W., & Strasser, A. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.11.004 · Cited by 287
Self-citationCastle, V. P., Heidelberger, K. P., Bromberg, J., Ou, X., Dole, M. G., & Núñez, G. (1993) · PubMed · Cited by 283
Noxa: at the tip of the balance between life and death
Ploner, C., Kofler, R., & Villunger, A. (2008) · Oncogene · doi:10.1038/onc.2009.46 · Cited by 283
Robertson, L. E., Plunkett, W. K., McConnell, K., Keating, M. J., & McDonnell, T. J. (1996) · PubMed · Cited by 281
Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction
Wang, X., Bathina, M., Lynch, J., Koss, B., Calabrese, C., Frase, S., Schuetz, J. D., Rehg, J. E., & Opferman, J. T. (2013) · Genes & Development · doi:10.1101/gad.215855.113 · Cited by 279
Degenerative Disorders Caused by Bcl-2 Deficiency Prevented by Loss of Its BH3-Only Antagonist Bim
Bouillet, P., Cory, S., Zhang, L.-C., Strasser, A., & Adams, J. M. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00083-1 · Cited by 274
Self-citationTesticular degeneration in Bclw-deficient mice
Ross, A. J., Waymire, K. G., Moss, J. E., Parlow, A. F., Skinner, M. K., Russell, L. D., & MacGregor, G. R. (1998) · Nature Genetics · doi:10.1038/ng0398-251 · Cited by 269
Loss of MCL-1 leads to impaired autophagy and rapid development of heart failure
Thomas, R. L., Roberts, D. J., Kubli, D. A., Lee, Y., Quinsay, M. N., Owens, J. B., Fischer, K. M., Sussman, M. A., Miyamoto, S., & Gustafsson, Å. B. (2013) · Genes & Development · doi:10.1101/gad.215871.113 · Cited by 269
BOK Is a Non-canonical BCL-2 Family Effector of Apoptosis Regulated by ER-Associated Degradation
Llambi, F., Wang, Y.-M., Victor, B., Yang, M., Schneider, D. M., Gingras, S., Parsons, M. J., Zheng, J. H., Brown, S. A., Pelletier, S., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.026 · Cited by 261
BH3-only Protein Noxa Is a Mediator of Hypoxic Cell Death Induced by Hypoxia-inducible Factor 1α
Kim, J.-Y., Ahn, H.-J., Ryu, J.-H., Suk, K., & Park, J.-H. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20030613 · Cited by 261
miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines
Lin, C. J.-F., Gong, H.-Y., Tseng, H.-C., Wang, W.-L., & Wu, J.-L. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.154 · Cited by 256
Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas
Mestre-Escorihuela, C., Rubio-Moscardo, F., Richter, J. A., Siebert, R., Climent, J., Fresquet, V., Beltran, E., Agirre, X., Marugan, I., Marín, M., et al. (2007) · Blood · doi:10.1182/blood-2006-06-026500 · Cited by 246
Huang, D. C., Cory, S., & Strasser, A. (1997) · Oncogene · doi:10.1038/sj.onc.1200848 · Cited by 242
Self-citationErlacher, M., Labi, V., Manzl, C., Böck, G., Tzankov, A., Häcker, G., Michalak, E., Strasser, A., & Villunger, A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061552 · Cited by 233
Self-citationRegulation of Bcl-xL: a little bit of this and a little bit of STAT
Grad, J. M., Zeng, X.-R., & Boise, L. H. (2000) · Current Opinion in Oncology · doi:10.1097/00001622-200011000-00006 · Cited by 231
Delving deeper: MCL-1's contributions to normal and cancer biology
Perciavalle, R. M., & Opferman, J. T. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.08.011 · Cited by 230
Grossmann, M. (2000) · The EMBO Journal · doi:10.1093/emboj/19.23.6351 · Cited by 227
Kobayashi, S., Werneburg, N. W., Bronk, S. F., Kaufmann, S. H., & Gores, G. J. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.010 · Cited by 226
Expression of bcl-2 in small cell lung carcinoma cells.
Ikegaki, N., Katsumata, M., Minna, J. D., & Tsujimoto, Y. (1994) · PubMed · Cited by 220
Regulation of Bim in Health and Disease
Sionov, R. V., Vlahopoulos, S. A., & Granot, Z. (2015) · Oncotarget · doi:10.18632/oncotarget.5492 · Cited by 216
Mcl-1 Is Essential for Germinal Center Formation and B Cell Memory
Vikstrom, I., Carotta, S., Lüthje, K., Peperzak, V., Jost, P. J., Glaser, S., Busslinger, M., Bouillet, P., Strasser, A., Nutt, S. L., et al. (2010) · Science · doi:10.1126/science.1191793 · Cited by 215
Self-citationCragg, M. S., Jansen, E. S., Cook, M., Harris, C., Strasser, A., & Scott, C. L. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35437 · Cited by 207
Self-citationMichalak, E. M., Villunger, A., Adams, J. M., & Strasser, A. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.16 · Cited by 205
Self-citationEmbryogenesis and Adult Life in the Absence of Intrinsic Apoptosis Effectors BAX, BAK, and BOK
Ke, F. F. S., Vanyai, H. K., Cowan, A. D., Delbridge, A. R. D., Whitehead, L., Grabow, S., Czabotar, P. E., Voss, A. K., & Strasser, A. (2018) · Cell · doi:10.1016/j.cell.2018.04.036 · Cited by 205
Self-citationMCL-1 is a prognostic indicator and drug target in breast cancer
Campbell, K. J., Dhayade, S., Ferrari, N., Sims, A. H., Johnson, E., Mason, S. M., Dickson, A., Ryan, K. M., Kalna, G., Edwards, J., et al. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0035-2 · Cited by 200
Zhang, X. D., Gillespie, S. K., Borrow, J. M., & Hersey, P. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.425.3.4 · Cited by 190
High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2
Zhou, Y., Chen, L., Barlogie, B., Stephens, O., Wu, X., Williams, D. R., Cartron, M.-A., van Rhee, F., Nair, B., Waheed, S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908441107 · Cited by 190
Bax and Bak Pores: Are We Closing the Circle?
Cosentino, K., & García-Sáez, A. J. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.11.004 · Cited by 190
Innate immunodeficiency following genetic ablation of Mcl1 in natural killer cells
Sathe, P., Delconte, R. B., Souza-Fonseca-Guimaraes, F., Seillet, C., Chopin, M., Vandenberg, C. J., Rankin, L. C., Mielke, L. A., Vikstrom, I., Kolesnik, T. B., et al. (2014) · Nature Communications · doi:10.1038/ncomms5539 · Cited by 187
Self-citationZhou, P., Levy, N. B., Xie, H., Qian, L., Lee, C.-Y. G., Gascoyne, R. D., & Craig, R. W. (2001) · Blood · doi:10.1182/blood.v97.12.3902 · Cited by 186
Unleashing the power of inhibitors of oncogenic kinases through BH3 mimetics
Cragg, M. S., Harris, C., Strasser, A., & Scott, C. L. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2615 · Cited by 185
Self-citationMerino, D., Whittle, J. R., Vaillant, F., Serrano, A., Gong, J.-N., Giner, G., Maragno, A. L., Chanrion, M., Schneider, E., Pal, B., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aam7049 · Cited by 185
The essentials of developmental apoptosis
Voss, A. K., & Strasser, A. (2020) · F1000Research · doi:10.12688/f1000research.21571.1 · Cited by 183
Self-citationCarrington, E. M., Zhan, Y., Brady, J. L., Zhang, J., Sutherland, R. M., Anstee, N. S., Schenk, R. L., Vikstrom, I. B., Delconte, R. B., Segal, D., et al. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.30 · Cited by 182
Self-citationABL Oncogenes and Phosphoinositide 3-Kinase: Mechanism of Activation and Downstream Effectors
Kharas, M. G., & Fruman, D. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3888 · Cited by 181
Suppression of tumorigenesis by the p53 target PUMA
Hemann, M. T., Zilfou, J. T., Zhao, Z., Burgess, D. J., Hannon, G. J., & Lowe, S. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403286101 · Cited by 179
DNA repair processes are critical mediators of p53-dependent tumor suppression
Janic, A., Valente, L. J., Wakefield, M. J., Di Stefano, L., Milla, L., Wilcox, S., Yang, H., Tai, L., Vandenberg, C. J., Kueh, A. J., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0043-5 · Cited by 179
Self-citationMoujalled, D. M., Pomilio, G., Ghiurau, C., Ivey, A., Salmon, J., Rijal, S., Macraild, S., Zhang, L., Teh, T.-C., Tiong, I.-S., et al. (2019) · Leukemia · doi:10.1038/s41375-018-0261-3 · Cited by 174
Expression of Bcl-xL in ovarian carcinoma is associated with chemoresistance and recurrent disease
Williams, J., Lucas, P. C., Griffith, K. A., Choi, M., Fogoros, S., Hu, Y. Y., & Liu, J. R. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.10.026 · Cited by 173
Rapid Turnover of Mcl-1 Couples Translation to Cell Survival and Apoptosis
Adams, K. W., & Cooper, G. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610643200 · Cited by 170
Selection against PUMA Gene Expression in Myc-Driven B-Cell Lymphomagenesis
Garrison, S. P., Jeffers, J. R., Yang, C., Nilsson, J. A., Hall, M. A., Rehg, J. E., Yue, W., Yu, J., Zhang, L., Onciu, M. M., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00907-07 · Cited by 169
Small-molecule inhibitors of the Myc oncoprotein
Fletcher, S., & Prochownik, E. V. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.03.005 · Cited by 167
MicroRNAs in cancer cell death pathways: Apoptosis and necroptosis
Shirjang, S., Mansoori, B., Asghari, S., Duijf, P. H. G., Mohammadi, A., Gjerstorff, M., & Baradaran, B. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.05.017 · Cited by 167
Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53
Kelly, G. L., Grabow, S., Glaser, S. P., Fitzsimmons, L., Aubrey, B. J., Okamoto, T., Valente, L. J., Robati, M., Tai, L., Fairlie, W. D., et al. (2014) · Genes & Development · doi:10.1101/gad.232009.113 · Cited by 166
Self-citationPF-04691502, a Potent and Selective Oral Inhibitor of PI3K and mTOR Kinases with Antitumor Activity
Yuan, J., Mehta, P. P., Yin, M.-J., Sun, S., Zou, A., Chen, J., Rafidi, K., Feng, Z., Nickel, J., Engebretsen, J., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0185 · Cited by 163
Yano, T., Ito, K., Fukamachi, H., Chi, X.-Z., Wee, H.-J., Inoue, K.-I., Ida, H., Bouillet, P., Strasser, A., Bae, S.-C., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01926-05 · Cited by 161
Self-citationTargeting the Bcl-2 Family in B Cell Lymphoma
Adams, C. M., Clark-Garvey, S., Porcu, P., & Eischen, C. M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2018.00636 · Cited by 159
Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors
Zhang, S., Zhang, M., Jing, Y., Yin, X., Ma, P., Zhang, Z., Wang, X., Di, W. J., & Zhuang, G. (2018) · Nature Communications · doi:10.1038/s41467-017-02693-9 · Cited by 158
VEGF induces Mcl-1 up-regulation and protects multiple myeloma cells against apoptosis
Gouill, S. L., Podar, K., Amiot, M., Hideshima, T., Chauhan, D., Ishitsuka, K., Kumar, S. K., Raje, N. S., Richardson, P. G. G., Harousseau, J., et al. (2004) · Blood · doi:10.1182/blood-2004-05-1760 · Cited by 155
Campbell, K. J., Bath, M. L., Turner, M. L., Vandenberg, C. J., Bouillet, P., Metcalf, D., Scott, C. L., & Cory, S. (2010) · Blood · doi:10.1182/blood-2010-04-281071 · Cited by 152
Pradelli, L. A., Bénéteau, M., Chauvin, C., Jacquin, M. A., Marchetti, S., Muñoz‐Pinedo, C., Auberger, P., Pende, M., & Ricci, J. (2009) · Oncogene · doi:10.1038/onc.2009.448 · Cited by 151
Schmelzle, T., Mailleux, A., Overholtzer, M., Carroll, J. S., Solimini, N. L., Lightcap, E. S., Veiby, O. P., & Brugge, J. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700115104 · Cited by 149
Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis
Michalak, E. M., Jansen, E. S., Happo, L., Cragg, M. S., Tai, L., Smyth, G. K., Strasser, A., Adams, J. M., & Scott, C. L. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.195 · Cited by 147
Self-citationAntiapoptotic bcl-2 and bcl-xL in advanced malignant melanoma
Leiter, U., Schmid, R. M., Kaskel, P., Peter, R. U., & Krähn, G. M. (2000) · Archives of Dermatological Research · doi:10.1007/s004030050479 · Cited by 144
Bae, I. H., Park, M., Yoon, S. H., Kang, S. W., Lee, S., Choi, K.-M., & Um, H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4254 · Cited by 143
Jourdan, M., Vos, J. D., Mechti, N., & Klein, B. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400758 · Cited by 142
Michalak, E. M., Vandenberg, C. J., Delbridge, A. R. D., Wu, L., Scott, C. L., Adams, J. M., & Strasser, A. (2010) · Genes & Development · doi:10.1101/gad.1940110 · Cited by 135
Self-citationZhou, W., Xu, J., Li, H., Xu, M., Chen, Z. J., Wei, W., Pan, Z., & Sun, Y. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1585 · Cited by 133
Hussain, S.-R. A., Cheney, C. M., Johnson, A. J., Lin, T. S., Grever, M. R., Caligiuri, M. A., Lucas, D. M., & Byrd, J. C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2294 · Cited by 132
Glucose Metabolism Attenuates p53 and Puma-dependent Cell Death upon Growth Factor Deprivation
Zhao, Y., Coloff, J. L., Ferguson, E. C., Jacobs, S. R., Cui, K., & Rathmell, J. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803580200 · Cited by 132
Hikita, H., Takehara, T., Shimizu, S., Kodama, T., Li, W., Miyagi, T., Hosui, A., Ishida, H., Ohkawa, K., Kanto, T., et al. (2009) · Hepatology · doi:10.1002/hep.23126 · Cited by 130
Matthews, G. M., Newbold, A., & Johnstone, R. W. (2012) · Advances in cancer research · doi:10.1016/b978-0-12-394387-3.00005-7 · Cited by 128
Labi, V., Erlacher, M., Kießling, S., Manzl, C., Frenzel, A., O’Reilly, L. A., Strasser, A., & Villunger, A. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071658 · Cited by 127
Self-citationApoptosis induced by histone deacetylase inhibitors in leukemic cells is mediated by Bim and Noxa
Inoue, S., Riley, J., Gant, T. W., Dyer, M. J. S., & Cohen, G. M. (2007) · Leukemia · doi:10.1038/sj.leu.2404760 · Cited by 125
Ekoff, M., Kaufmann, T., Engström, M., Motoyama, N., Villunger, A., Jönsson, J., Strasser, A., & Nilsson, G. P. (2007) · Blood · doi:10.1182/blood-2007-02-073957 · Cited by 125
Self-citationMiR-26a Inhibits Proliferation and Migration of Breast Cancer through Repression of MCL-1
Gao, J., Li, L., Wu, M., Liu, M., Xie, X., Guo, J., Tang, H., & Xie, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065138 · Cited by 121
Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma
Richter, J. Á., Robles, E. F., Fresquet, V., Beltrán, E., Rullan, A., Agirre, X., Calasanz, M. J., Panizo, C., Richter, J. Á., Hernández‐Rivas, J. M., et al. (2010) · Blood · doi:10.1182/blood-2010-02-268003 · Cited by 119
Happo, L., Cragg, M. S., Phipson, B., Haga, J. M., Jansen, E. S., Herold, M. J., Dewson, G., Michalak, E. M., Vandenberg, C. J., Smyth, G. K., et al. (2010) · Blood · doi:10.1182/blood-2010-04-280818 · Cited by 117
Self-citationAntiapoptotic potency of Bcl-2 proteins primarily relies on their stability, not binding selectivity
Rooswinkel, R. W., van de Kooij, B., de Vries, E., Paauwe, M., Braster, R., Verheij, M., & Borst, J. G. (2014) · Blood · doi:10.1182/blood-2013-08-519470 · Cited by 116
PUMA expression is significantly reduced in human cutaneous melanomas
Karst, A. M., Dai, D. L., Martinka, M., & Li, G. (2004) · Oncogene · doi:10.1038/sj.onc.1208374 · Cited by 113
Tissue expression and subcellular localization of the pro-survival molecule Bcl-w
O’Reilly, L. A., Print, C. G., Hausmann, G., Moriishi, K., Cory, S., Huang, D. C. S., & Strasser, A. (2001) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400835 · Cited by 113
Self-citationBCL-2 family protein expression and platinum drug resistance in ovarian carcinoma
Beale, P. J., Rogers, P., Boxall, F. E., Sharp, S. Y., & Kèlland, L. R. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0939 · Cited by 112
O’Reilly, L. A., Kruse, E., Puthalakath, H., Kelly, P. N., Kaufmann, T., Huang, D. C. S., & Strasser, A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803853 · Cited by 110
Self-citationBCL-2 Proteins in Pathogenesis and Therapy of B-Cell Non-Hodgkin Lymphomas
Klánová, M., & Klener, P. (2020) · Cancers · doi:10.3390/cancers12040938 · Cited by 105
Expression of bcl-2 — protein in small cell lung cancer
Kaiser, U., Schilli, M., Haag, U., Neumann, K., Kreipe, H. H., Коган, Е. А., & HAVEMANN, K. (1996) · Lung Cancer · doi:10.1016/0169-5002(96)00568-5 · Cited by 104
Zantl, N., Weirich, G., Zall, H., Seiffert, B. M., Fischer, S. F., Kirschnek, S., Hartmann, C., Fritsch, R., Gillissen, B. F., Daniel, P. T., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210510 · Cited by 101
Lestini, B. J., Goldsmith, K. C., Fluchel, M. N., Liu, X., Chen, N., Goyal, B., Pawel, B., & Hogarty, M. D. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.16.8964 · Cited by 100
Wildey, G. M., Patil, S. D., & Howe, P. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211958200 · Cited by 98
BIM Is the Primary Mediator of MYC-Induced Apoptosis in Multiple Solid Tissues
Muthalagu, N., Junttila, M. R., Wiese, K. E., Wolf, E., Morton, J. P., Bauer, B., Evan, G. I., Eilers, M., & Murphy, D. J. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.057 · Cited by 97
Prognostic Impact of Bim, Puma, and Noxa Expression in Human Colon Carcinomas
Sinicrope, F. A., Rego, R. L., Okumura, K., Foster, N. R., O’Connell, M. J., Sargent, D. J., & Windschitl, H. E. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5202 · Cited by 97
Nangia, V., Siddiqui, F. M., Caenepeel, S., Timonina, D., Bilton, S. J., Phan, N., Gomez-Caraballo, M., Archibald, H. L., Li, C., Fraser, C., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0277 · Cited by 94
Predominant expression of the long isoform of Bcl‐x (Bcl‐xL) in human lymphomas
Xerri, L., Parc, P., Brousset, P., Schlaifer, D., Hassoun, J., Reed, J. C., Krajewski, S., & Birnbaum, D. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.423958.x · Cited by 94
José‐Eneriz, E. S., Agirre, X., Jiménez‐Velasco, A., Cordeu, L., Martín, V., Arqueros, V., Gárate, L., Fresquet, V., Cervantes, F., Martinez-Climent, J. A., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.04.005 · Cited by 94
Duvelisib: A 2018 Novel FDA-Approved Small Molecule Inhibiting Phosphoinositide 3-Kinases
Rodrigues, D. A., Sagrillo, F. S., & Fraga, C. A. M. (2019) · Pharmaceuticals · doi:10.3390/ph12020069 · Cited by 94
Post-transcriptional and post-translational regulation of Bcl2
Willimott, S., & Wagner, S. D. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381571 · Cited by 92
EGF-mediated induction of Mcl-1 at the switch to lactation is essential for alveolar cell survival
Fu, N. Y., Rios, A. C., Pal, B., Soetanto, R., Lun, A. T. L., Liu, K., Beck, T. J., Best, S. A., Vaillant, F., Bouillet, P., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3117 · Cited by 91
Self-citationWang, K., Jin, W., Song, Y., & Fei, X. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0735-3 · Cited by 91
Molitoris, J. K., McColl, K. S., & Distelhorst, C. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0402 · Cited by 90
Kucharczak, J., Simmons, M. J., Duckett, C. S., & Gélinas, C. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401684 · Cited by 87
Pore formation by dimeric Bak and Bax: an unusual pore?
Uren, R. T., Iyer, S., & Kluck, R. M. (2017) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0218 · Cited by 86
Stam, R. W., den Boer, M. L., Schneider, P., de Boer, J., Spijkers-Hagelstein, J. A. P., Valsecchi, M. G., Lorenzo, P. D., Sallan, S. E., Brady, H. J. M., Armstrong, S. A., et al. (2009) · Blood · doi:10.1182/blood-2009-02-205963 · Cited by 84
Martin, S. S., Ridgeway, A. G., Pinkas, J., Lu, Y., Reginato, M. J., Koh, E. Y., Ventosa-Michelman, M., Daley, G. Q., Brugge, J. S., & Leder, P. (2004) · Oncogene · doi:10.1038/sj.onc.1207595 · Cited by 83
Cited by
Targeted protein degradation: advances in drug discovery and clinical practice
Zhong, G., Chang, X., Xie, W., & Zhou, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02004-x · Cited by 326
Shao, M., Zhang, X., Sun, J., Dong, H., Han, X., Yang, Q., Chen, R., Shen, L., Xu, L., Wang, L., et al. (2025) · Exploration · doi:10.1002/exp.70000 · Cited by 26
Metadata
- Authors
- Kaloni, D., Diepstraten, S. T., Strasser, A., & Kelly, G. L.
- Venue
- Apoptosis
- Published
- 2022-11-07
- Volume
- 28
- Issue
- 1-2
- Pages
- 20-38
- ISSN
- 1360-8185 (ISSN-L)
- 1573-675X
- OpenAlex
- W4308365352
- Cited by
- 500
- References
- 247
- FWCI
- 27.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.